Evidence map›Paper›PMID 28199840›Full record

ArticleCell reports2017

Citron Kinase Deficiency Leads to Chromosomal Instability and TP53-Sensitive Microcephaly.

Federico Tommaso Bianchi, Chiara Tocco, Gianmarco Pallavicini, Yifan Liu, Fiammetta Vernì, Chiara Merigliano, Silvia Bonaccorsi, Nadia El-Assawy, Lorenzo Priano, Marta Gai and 12 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. P53 independent pathogenic mechanisms contribute to BubR1 microcephaly.Frontiers in cell and developmental biology · 2023
    Article
  13. DNA damage and repair: underlying mechanisms leading to microcephaly.Frontiers in cell and developmental biology · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 2 countries.

Federico Tommaso BianchiDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy; Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano (TO), Italy. Electronic address: federico.bianchi@unito.it.
Chiara ToccoDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.
Gianmarco PallaviciniDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy; Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano (TO), Italy.
Yifan LiuDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.
Fiammetta VernìDepartment of Biology and Biotechnology "Charles Darwin," Sapienza University, 00185 Rome, Italy.
Chiara MeriglianoDepartment of Biology and Biotechnology "Charles Darwin," Sapienza University, 00185 Rome, Italy.
Silvia BonaccorsiDepartment of Biology and Biotechnology "Charles Darwin," Sapienza University, 00185 Rome, Italy.
Nadia El-AssawyDepartment of Neurology and Neurorehabilitation, San Giuseppe Hospital, Istituto Auxologico Italiano IRCCS, 28824 Piancavallo (VB), Italy.
Lorenzo PrianoDepartment of Neurology and Neurorehabilitation, San Giuseppe Hospital, Istituto Auxologico Italiano IRCCS, 28824 Piancavallo (VB), Italy; Department of Neuroscience, University of Torino, 10126 Torino, Italy.
Marta GaiDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.
Gaia Elena BertoDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy; Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano (TO), Italy.
Alessandra Maria Adelaide ChiottoDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy; Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano (TO), Italy.
Francesco SgròDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.
Alessia CaramelloDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.
Laura TascaDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy; Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano (TO), Italy.
Ugo AlaDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy.
Francesco NeriHuman Genetics Foundation (HuGeF), via Nizza 52, 10126 Torino, Italy.
Salvatore OlivieroHuman Genetics Foundation (HuGeF), via Nizza 52, 10126 Torino, Italy.
Alessandro MauroDepartment of Neurology and Neurorehabilitation, San Giuseppe Hospital, Istituto Auxologico Italiano IRCCS, 28824 Piancavallo (VB), Italy; Department of Neuroscience, University of Torino, 10126 Torino, Italy.
Stephan GeleyDivision of Molecular Pathophysiology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Maurizio GattiDepartment of Biology and Biotechnology "Charles Darwin," Sapienza University, 00185 Rome, Italy; Institute of Molecular Biology and Pathology (IBPM), CNR, 00185 Rome, Italy.
Ferdinando Di CuntoDepartment of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy; Neuroscience Institute Cavalieri Ottolenghi, University of Turin, 10043 Orbassano (TO), Italy. Electronic address: ferdinando.dicunto@unito.it.
University of Turin · ITNeuroscience Institute · ITSapienza University of Rome · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITItalian institute for Genomic Medicine · ITInnsbruck Medical University · ATInstitute of Molecular Biology and Pathology · ITIRCCS Istituto Auxologico Italiano · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in citron (CIT), leading to loss or inactivation of the citron kinase protein (CITK), cause primary microcephaly in humans and rodents, associated with cytokinesis failure and apoptosis in neural progenitors. We show that CITK loss induces DNA damage accumulation and chromosomal instability in both mammals and Drosophila. CITK-deficient cells display "spontaneous" DNA damage, increased sensitivity to ionizing radiation, and defective recovery from radiation-induced DNA lesions. In CITK-deficient cells, DNA double-strand breaks increase independently of cytokinesis failure. Recruitment of RAD51 to DNA damage foci is compromised by CITK loss, and CITK physically interacts with RAD51, suggesting an involvement of CITK in homologous recombination. Consistent with this scenario, in doubly CitK and Trp53 mutant mice, neural progenitor cell death is dramatically reduced; moreover, clinical and neuroanatomical phenotypes are remarkably improved. Our results underscore a crucial role of CIT in the maintenance of genomic integrity during brain development.

Indexed as

AnimalsChromosomal InstabilityCytokinesisDNA Breaks, Double-StrandedDNA DamageDNA RepairDrosophilaHomologous RecombinationIntracellular Signaling Peptides and ProteinsMammalsMiceMicrocephalyProtein Serine-Threonine KinasesRad51 RecombinaseRadiation, IonizingTumor Suppressor Protein p53citron-kinaseIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesRad51 RecombinaseTumor Suppressor Protein p53apoptosiscitron kinasecytokinesisDNA damagedouble strand breaksgenome instabilitymicrocephalyRAD51TP53

Identifiers

PMID28199840
PMCPMC5318669
OpenAlexW2588238986

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.